A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S-649266 Compared With Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram-negative Pathogens
Phase of Trial: Phase III
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Cefiderocol (Primary) ; Linezolid; Meropenem
- Indications Nosocomial pneumonia
- Focus Registrational; Therapeutic Use
- Acronyms APEKS-NP
- Sponsors Shionogi
- 19 Jul 2017 Status changed from not yet recruiting to recruiting.
- 18 May 2017 Planned initiation date changed from 1 May 2017 to 15 Jul 2017.
- 02 Feb 2017 New trial record